Видео с ютуба Functionally High-Risk Myeloma

What does it mean to have functional high-risk multiple myeloma?

Cilta-cel versus SoC in functionally high-risk myeloma with one prior therapy

Real-world treatment patterns & outcomes of functional high-risk myeloma

Functional High-Risk Myeloma:CAR-T Optimizes Outcomes at Relapse | Rahul Banerjee, MD | #IMS2025

FAQs on High-Risk Disease

The impact of functionally high-risk disease in patients with R/R myeloma receiving late-line CAR-T

Defining Functional High-Risk Myeloma & Why Its Important | Barry Paul, MD & Todd Kennedy | #ASH25

My Self Advocacy Journey with Ultra High-Risk Multiple Myeloma

Approaching and managing relapsed high-risk myeloma

The impact of induction therapy on outcomes for patients with functional high-risk myeloma

Identifying and treating high-risk patients in 2023

Identifying high-risk multiple myeloma patient subgroups using genetic and clinical factors

Approaches to risk stratification in high risk myeloma

Defining and managing high-risk myeloma

High-risk myeloma: How and should it be treated differently

High-Risk vs. Standard-Risk Multiple Myeloma: What Patients Need to Know in 1 Minute

Managing patients with difficult to treat multiple myeloma

What is HRMM (High-Risk Multiple Myeloma)? #myeloma

Cytogenetics and High Risk Mutations in Multiple Myeloma – Dr. Shaina Rozell

Defining high-risk myeloma